|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.81 USD | -3.84% |
|
-5.96% | +27.59% |
| 02-20 | UBS Adjusts Price Target on 10x Genomics to $20 From $14, Maintains Neutral Rating | MT |
| 02-12 | 10x Genomics, Inc., Q4 2025 Earnings Call, Feb 12, 2026 |
17d1ad80d2a31f434aeea7595.uDN6s9WUosTfgovL_Q78I9hhgOuwvOtUlsjs3D6ZvnE.8wQ-66PlxYaY8MGPhF-sRqFQ9Mby67Ek7K-ijw3RxCjCRTaLuLnoqIb3vw~5e622a048cfd88f07669f39d239cd5b2
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















